0114 232 9292 connect@medilink.co.uk

Medilink Corporate Partner Nabarro Releases Latest Report

Medilink Corporate Partner Nabarro has released their latest report 'Taking AIM: ambition and fear in the UK tech sector'. 

For US technology companies with “unicorn” ambitions, listing on Nasdaq is seen as a
natural step – a means to raise new capital for growth and to realise the investment of early investors.35

In the UK, the AIM market, which is designed for growth companies, should offer a similar solution. However, according to Nabarro’s research, tech companies in the UK are less likely to think of AIM as a source of capital or a step towards an exit. Meanwhile, investors would like to see a greater number of tech stocks with a listing on AIM. This report unpicks the contradiction between the appetite of investors and the ambitions and fears of founders.

Click here to discover more about the report. Or to download the report click here. 

Comments are closed.